Systems, methods, and formulations for treating cancer
AssigneeResearch Cancer Institute of America
InventorMohammad Amin Nezami
Life of this patent
Estimating the term…
Abstract
A method and compositions for treating cancer is described using at least two epigenetic modifiers. In various embodiments, hyperbaric oxygen therapy and glycolytic inhibition therapy are used as well.
Claims12
A pharmaceutical formulation for the prophylaxis or treatment of cancer, comprising two or more epigenetic modifiers.
3-18. (canceled)
A unit dose of a pharmaceutical formulation for treatment of cancer comprising two or more epigenetic modifiers in a combined form, wherein the epigenetic modifiers are present in a dosage sufficient to cause tumor response in a human as measured by laboratory and/or radiologic studies after administration of between about 1 unit doses and about 60 unit doses.
(canceled)
A kit comprising:
- a unit dose of a pharmaceutical formulation for treatment of cancer comprising two or more epigenetic modifiers;
- a container wherein the unit dose is at least partially contained.
22-26. (canceled)
A method of treatment comprising:
- administering one or more epigenetic modifiers and/or glycolytic inhibitors to a mammal;
- and subjecting the mammal to a hyperbaric oxygen environment.
28-54. (canceled)
A method of treatment comprising:
- administering one or more glycolytic inhibitors to mammal;
- and administering one or more epigenetic modifiers to the mammal.
56-59. (canceled)
Dependencies are inferred from the claim text.